Jejunal Feeding Via Gastrojejunal Tube in Refractory Gastroesophageal Reflux
Sponsored by Assistance Publique - Hôpitaux de Paris
About this trial
Last updated 3 years ago
Study ID
APHP-ReJej
Status
Recruiting
Type
Observational
Placebo
No
Accepting
1 to 18 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
Gastroesophageal reflux disease (GERD) in children can be severe and lead to multiple
complications, dizziness, esophagitis, respiratory failure or ENT infections.
In the case of resistance to treatment with proton pump inhibitors (PPIs), alternatives
treatments includes antireflux surgery or fasting associated with parenteral nutrition. The
use of gastrointestinal tubes (GJT) is relatively recent. Its objective is to allow a direct
jejunal feeding, thus limiting the risk of severe gastroesophageal reflux disease (GERD).
Jejunal feeding using GJT has been compared to surgical techniques without finding any
superiority. However, the risk of GERD recurrence appears to be greater if anti-reflux
surgery is performed in a young child. As an alternative to anti-reflux surgery, prolonged
parenteral nutrition (NPE) is burdened with its own morbidity (metabolic, infectious,
vascular). In addition, the natural course of GERD is usually towards spontaneous improvement
with the age and growth of the child. GJT may be used to postpone anti-reflux surgery and
prevent NPE while waiting for spontaneous GERD improvement. In a cohort of 27 children, 5 did
not require surgery or parenteral nutrition after placement of GJT . However, this study is
difficult to analyze because of 9/27 deaths. Complications from GJT are common, ranging from
obstruction requiring replacement to jejunal perforation. We will study the benefit of
jejunal feeding on YSG for children followed for severe GERD.
References :
1. Srivastava R, Downey EC, O'Gorman M, Feola P, Samore M, Holubkov R, et al. Impact of
fundoplication versus gastrojejunal feeding tubes on mortality and in preventing
aspiration pneumonia in young children with neurologic impairment who have
gastroesophageal reflux disease. Pediatrics 2009; 123:338-45.
2. Stone B, Hester G, Jackson D, Richardson T, Hall M, Gouripeddi R, et al. Effectiveness
of Fundoplication or Gastrojejunal Feeding in Children With Neurologic Impairment. Hosp
Pediatr 2017; 7:140-8.
3. Michaud L, Coopman S, Guimber D, Sfeir R, Turck D, Gottrand F. Percutaneous
gastrojejunostomy in children: efficacy and safety. Arch Dis Child 2012; 97:733-4.
4. Campwala I, Perrone E, Yanni G, Shah M, Gollin G. Complications of gastrojejunal feeding
tubes in children. J Surg Res 2015; 199:67-71.
What are the participation requirements?
Inclusion Criteria
- Children under 18
- Insertion of a gastro-jejunal tube with a goal of feeding by the jejunal route during GERD beyond 1/1/2000
- Follow-up> 4 months.
- Follow-up at Robert-Debré hospital
Exclusion Criteria
- Refusal to participate in the study
- intra-gastric Gastro-jejunal tube placement, with the aim of gastric emptying
Locations
Location
Status
Recruiting